Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly and | Svizzera | Salute | Prodotti farmaceutici | 559,84 Mrd CHF | 62x | 0,76 | 630 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Roche Holding | Svizzera | Salute | Prodotti farmaceutici | 219,21 Mrd CHF | 26,6x | -0,9 | 275,60 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 30,6% Rialzo | Fai l’upgrade a Pro+ | |
Roche Holding Participation | Svizzera | Salute | Prodotti farmaceutici | 206,25 Mrd CHF | 26,6x | -0,9 | 259,30 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 13,2% Rialzo | Fai l’upgrade a Pro+ | |
Abbott Laboratories | Svizzera | Salute | Attrezzature e forniture medicali | 189,18 Mrd CHF | 17,2x | 0,12 | 106 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Novartis | Svizzera | Salute | Prodotti farmaceutici | 185,91 Mrd CHF | 18,1x | -1,33 | 94,89 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 2,7% Rialzo | Fai l’upgrade a Pro+ | |
Novartis | Svizzera | Salute | Prodotti farmaceutici | 185,91 Mrd CHF | 18,1x | -1,33 | 95,10 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Lonza Group | Svizzera | Salute | Ricerca medica e biotecnologica | 39,57 Mrd CHF | 58x | 560,20 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,3% Rialzo | Fai l’upgrade a Pro+ | ||
Alcon | Svizzera | Salute | Attrezzature e forniture medicali | 34,79 Mrd CHF | 37,8x | 5,71 | 70,18 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 27,6% Rialzo | Fai l’upgrade a Pro+ | |
Sandoz | Svizzera | Salute | Prodotti farmaceutici | 18,79 Mrd CHF | 43,63 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -3,3% Ribasso | Fai l’upgrade a Pro+ | |||
Straumann Holding AG | Svizzera | Salute | Attrezzature e forniture medicali | 16,40 Mrd CHF | 35,8x | 0,62 | 102,85 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 25,4% Rialzo | Fai l’upgrade a Pro+ | |
Zimmer Biomet Holdings Inc | Svizzera | Salute | Attrezzature e forniture medicali | 14,76 Mrd CHF | 20,1x | -8,47 | 109 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Sonova H Ag | Svizzera | Salute | Attrezzature e forniture medicali | 14,50 Mrd CHF | 26,8x | -2,67 | 243,20 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 10,6% Rialzo | Fai l’upgrade a Pro+ | |
Ypsomed Holding AG | Svizzera | Salute | Attrezzature e forniture medicali | 5,52 Mrd CHF | 59,9x | 5,4 | 404,50 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 16,3% Rialzo | Fai l’upgrade a Pro+ | |
BACHEM HOLDING AG | Svizzera | Salute | Ricerca medica e biotecnologica | 4,37 Mrd CHF | 34,9x | 5,13 | 58,30 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,4% Rialzo | Fai l’upgrade a Pro+ | |
Galenica Sante | Svizzera | Salute | Prodotti farmaceutici | 4,29 Mrd CHF | 23,5x | -0,65 | 86,05 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -7,6% Ribasso | Fai l’upgrade a Pro+ | |
Siegfried Holding Ltd | Svizzera | Salute | Prodotti farmaceutici | 4,14 Mrd CHF | 26,6x | 0,64 | 94,50 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 20,3% Rialzo | Fai l’upgrade a Pro+ | |
Dottikon Es Holding AG | Svizzera | Salute | Prodotti farmaceutici | 3,95 Mrd CHF | 37,4x | 1,21 | 285,50 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 25,3% Rialzo | Fai l’upgrade a Pro+ | |
Lepu Medical Tech Beijing DRC | Svizzera | Salute | Attrezzature e forniture medicali | 2,68 Mrd CHF | 144,1x | -1,87 | 14,73 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Medacta | Svizzera | Salute | Attrezzature e forniture medicali | 2,59 Mrd CHF | 37,1x | 0,7 | 130,20 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 10,5% Rialzo | Fai l’upgrade a Pro+ | |
Joincare Pharmaceutical DRC | Svizzera | Salute | Prodotti farmaceutici | 2,27 Mrd CHF | 15,9x | -4,32 | 6,54 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
SKAN | Svizzera | Salute | Attrezzature e forniture medicali | 1,63 Mrd CHF | 41,7x | 0,88 | 72,50 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 24,1% Rialzo | Fai l’upgrade a Pro+ | |
BB Biotech | Svizzera | Salute | Ricerca medica e biotecnologica | 1,61 Mrd CHF | -3,9x | 0,02 | 29,70 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Aevis Victoria | Svizzera | Salute | Fornitori e servizi sanitari | 1,14 Mrd CHF | -377,9x | -4,27 | 13,50 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Kuros Biosciences | Svizzera | Salute | Ricerca medica e biotecnologica | 979,23 Mln CHF | -231x | -3,8 | 25,52 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Medartis | Svizzera | Salute | Attrezzature e forniture medicali | 926,05 Mln CHF | 276,1x | 0,57 | 74,70 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 19,4% Rialzo | Fai l’upgrade a Pro+ | |
COSMO Pharma | Svizzera | Salute | Prodotti farmaceutici | 893,64 Mln CHF | 7,3x | 0,01 | 55,80 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
PolyPeptide Group AG | Svizzera | Salute | Prodotti farmaceutici | 655,31 Mln CHF | -31,2x | -0,57 | 19,86 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 38,1% Rialzo | Fai l’upgrade a Pro+ | |
Basilea Pharmaceutica AG | Svizzera | Salute | Ricerca medica e biotecnologica | 599,30 Mln CHF | 7,6x | 0,01 | 48,85 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 34,1% Rialzo | Fai l’upgrade a Pro+ | |
medmix | Svizzera | Salute | Attrezzature e forniture medicali | 502,54 Mln CHF | -54,8x | 0,03 | 12,32 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Coltene Holding AG | Svizzera | Salute | Attrezzature e forniture medicali | 400,35 Mln CHF | 18,7x | 0,27 | 67 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -6,7% Ribasso | Fai l’upgrade a Pro+ |